The Molecular Biology laboratory was created for the continuous upgrade of the provided health services to the Cypriot citizens.
BIOIATRIKI Healthcare Group is committed to the provision of high-quality services, invests in modern infrastructure, highly trained personnel and high technology to meet the diagnostic needs created by the COVID-19 pandemic in Cypriot society.
The department follows the international analysis protocols and is equipped with an automatic genetic material elution analyzer in combination with 2 state-of-the-art Real Time PCR devices which can provide reliable results for the control of various viruses (influenza, Sars-Cov-2, RSV) as well as sexually transmitted diseases, according to the guidelines of the World Health Organization (WHO).
